Kevin Feige and Amy Pascal have confirmed that Marvel Studios still holds out hope for a live-action crossover between Tom Holland's Spider-Man and Tom Hardy's Venom, while also revealing that a fully animated Venom feature is actively in development at Sony. The duo shared both updates during an appearance on the Happy Sad Confused podcast with host Josh Horowitz, offering the clearest signal yet that the two most popular symbiote-adjacent characters in modern superhero cinema might finally share a frame — even if the timeline remains frustratingly vague.
The Podcast Exchange That Started It All
Horowitz pressed the pair on "how close" they've come to uniting the two characters after years of near-misses, post-credits teases, and multiversal loopholes that never quite paid off. Pascal responded with diplomatic warmth: "It would be great, let's put it that way." When Horowitz followed up by asking if Feige had hope, the Marvel Studios chief offered his signature measured optimism: "We always have hope." Pascal then playfully doubled down: "I have hope. We have hope."
The exchange was light on specifics — no dates, no script confirmations, no casting announcements — but heavy on intention. For fans who have watched the Sony-Marvel relationship evolve from cautious partnership to full creative entanglement, the mere fact that both principals are still publicly aligned on the goal counts as progress.
Why This Conversation Is Happening Now
The timing isn't accidental. Spider-Man: Brand New Day arrives in theaters on July 31, 2026, marking Holland's fourth solo outing and the first since the multiverse-shattering events of No Way Home. That film's post-credits scene left a piece of the Venom symbiote behind in the MCU — a narrative breadcrumb that has gone entirely unpicked in the years since. Meanwhile, Sony's Venom: The Last Dance closed out Hardy's trilogy last fall to diminishing returns, both critical and commercial. The studio needs a new direction for the character, and the MCU needs a villain (or antihero) worthy of its next street-level saga.
The Animated Pivot: A Smarter Bet Than It Looks
While the live-action crossover remains in "hope" territory, the animated Venom film is concrete. Zach Lipovsky and Adam B. Stein, fresh off Final Destination: Bloodlines, are set to direct. Pascal is producing. Hardy is attached in an unspecified capacity — likely voice work, possibly creative input. The project was first reported on February 23, 2026, and represents a strategic shift for a franchise that has struggled to find tonal consistency in live action.
Animation solves several problems at once. It frees the symbiote from the uncanny-valley CGI that has plagued the Hardy films' action sequences. It allows for body horror and shape-shifting spectacle that would be prohibitively expensive or ratings-restrictive in live action. And it positions Sony to compete in the same space that Spider-Man: Across the Spider-Verse proved can be both critically revered and commercially massive.
The symbiote has always been a visual concept first — liquid motion, teeth, tendrils, eyes that aren't eyes. Animation isn't a compromise for this character. It's the natural medium.
The Rights Reality Check
Here's where the optimism meets the contract lawyers. Sony retains film rights to Venom and the broader Spider-Man adjacent roster. Marvel Studios produces the Holland Spider-Man films under a licensing agreement that has been renegotiated multiple times. Every crossover requires alignment between two corporate entities with different priorities, different release calendars, and different visions for what these characters represent.
We've been here before. No Way Home only happened after a very public breakdown in negotiations. Morbius and Madame Web arrived with MCU-adjacent marketing but zero narrative connectivity. The "hope" Feige and Pascal describe is genuine — but it's also a negotiating position, a public signal to shareholders and talent agents that the door remains open.
What the Animated Film Could Mean for the Live-Action Future
If the animated Venom film succeeds — critically, commercially, culturally — it creates a template. A version of the character that works, that audiences embrace, that exists in a visual language distinct from the MCU's house style. That success could make a live-action crossover easier to justify: Sony gets a proven creative team, Marvel gets a character with refreshed audience goodwill, and both sides get a clearer sense of what "Venom in the MCU" should actually look like.
Conversely, if the animated film stumbles, the pressure to course-correct with a high-profile live-action team-up only intensifies. Either way, the animated project isn't a side bet. It's the primary vehicle for the character's next chapter.
The Broader Trend: Superhero Animation Is Eating the Genre
This isn't happening in isolation. X-Men '97 proved serialized superhero animation can drive Disney+ engagement. Invincible showed adult-oriented superhero storytelling works outside the MCU's PG-13 ceiling. Spider-Verse rewrote the visual language of the entire medium. Sony's animated Venom film arrives into a landscape where the best superhero storytelling is increasingly happening in animation — not despite the medium, but because of it.
For a character defined by physical transformation and psychological duality, animation offers tools live action simply doesn't: literal internal monologues visualized as shifting biomass, memory sequences rendered in symbiote-fluid abstraction, action choreography unconstrained by stunt physics or actor availability.
What Comes Next
Spider-Man: Brand New Day hits theaters this summer. The animated Venom film has directors and a producer but no announced release window — though a 2027 or 2028 debut feels plausible given typical animation pipelines. Holland has said "one day, I'm sure we'll get to see the symbiote" in his MCU tenure. Feige and Pascal have now said they have hope.
Hope isn't a schedule. But in an industry where IP management usually trumps creative instinct, two of the most powerful producers in superhero cinema standing on a podcast and saying "we want this to happen" is the closest thing to a greenlight the public gets. The symbiote is waiting. The web-slinger is swinging. The only question is whether the contracts catch up to the imagination.
Comments (0)
Loading comments…